Michael Garnreiter Sells 1,000 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Michael Garnreiter also recently made the following trade(s):

• On Tuesday, October 15th, Michael Garnreiter sold 1,000 shares of Axon Enterprise stock. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $635.76 on Wednesday. Axon Enterprise, Inc. has a 52-week low of $241.72 and a 52-week high of $698.67. The stock has a market cap of $48.48 billion, a PE ratio of 164.28, a P/E/G ratio of 14.19 and a beta of 1.01. The firm has a 50-day moving average of $548.26 and a 200-day moving average of $411.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Institutional Investors Weigh In On Axon Enterprise

Several hedge funds have recently bought and sold shares of the stock. Quent Capital LLC increased its stake in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Prestige Wealth Management Group LLC grew its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. Blue Trust Inc. increased its position in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the third quarter worth $41,000. Finally, Planning Capital Management Corp boosted its position in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AXON. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $488.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.